Gene therapy represents one of the fastest growing biotherapeutics worldwide, with AAV at the forefront. This rapid growth is constantly challenging CMC approaches, from manufacturing through release ...

AAVPureMfg produces high-purity AAV vectors with reduced plasmid cost, which holds tremendous clinical and commercial significance. Inherent limitations in triple transfection are elucidated.

CDMO 3PBIOVIAN officials report that the company has launched the AAVion ® platform, a fully integrated adeno-associated virus (AAV) manufacturing solution designed to accelerate gene therapy ...

Pacific Biosciences PACB has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table encapsulates their recent ...

PBGENE-DMD is designed to improve function over time and addresses more than 60% of patients afflicted with DMD by employing two complementary ARCUS nucleases delivered in a single AAV to excise ...

COLUMBUS, Ohio--(BUSINESS WIRE)--Forge Biologics (“Forge”), a leading manufacturer of genetic medicines and member of the Ajinomoto Bio-Pharma Services group, today announced an AAV ...

With time a critical factor, the team at Andelyn prioritized the program, transferred it in, and immediately got to work building a manufacturing process with their AAV Curator ® Platform moving ...